Skip to main content
PMC home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1986 Aug 1;103(2):521–534. doi: 10.1083/jcb.103.2.521

Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves

PMCID: PMC2113837  PMID: 3733877

Abstract

The labeling patterns produced by radioiodinated botulinum neurotoxin (125I-BoNT) types A and B at the vertebrate neuromuscular junction were investigated using electron microscopic autoradiography. The data obtained allow the following conclusions to be made. 125I-BoNT type A, applied in vivo or in vitro to mouse diaphragm or frog cutaneous pectoris muscle, interacts saturably with the motor nerve terminal only; silver grains occur on the plasma membrane, within the synaptic bouton, and in the axoplasm of the nerve trunk, suggesting internalization and retrograde intra-axonal transport of toxin or fragments thereof. 125I-BoNT type B, applied in vitro to the murine neuromuscular junction, interacts likewise with the motor nerve terminal except that a lower proportion of internalized radioactivity is seen. This result is reconcilable with the similar, but not identical, pharmacological action of these toxin types. The saturability of labeling in each case suggested the involvement of acceptors; on preventing the internalization step with metabolic inhibitors, their precise location became apparent. They were found on all unmyelinated areas of the nerve terminal membrane, including the preterminal axon and the synaptic bouton. Although 125I-BoNT type A interacts specifically with developing terminals of newborn rats, the unmyelinated plasma membrane of the nerve trunk is not labeled, indicating that the acceptors are unique components restricted to the nerve terminal area. BoNT types A and B have distinct acceptors on the terminal membrane. Having optimized the conditions for saturation of these binding sites and calibrated the autoradiographic procedure, we found the densities of the acceptors for types A and B to be approximately 150 and 630/micron 2 of membrane, respectively. It is proposed that these membrane acceptors target BoNT to the nerve terminal and mediate its delivery to an intracellular site, thus contributing to the toxin's selective inhibitory action on neurotransmitter release.

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURGEN A. S. V., DICKENS F., ZATMAN L. J. The action of botulinum toxin on the neuro-muscular junction. J Physiol. 1949 Aug;109(1-2):10–24. doi: 10.1113/jphysiol.1949.sp004364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnard E. A., Dolly J. O., Porter C. W., Albuquerque E. X. The acetylcholine receptor and the ionic conductance modulation system of skeletal muscle. Exp Neurol. 1975 Jul;48(1):1–28. doi: 10.1016/0014-4886(75)90219-8. [DOI] [PubMed] [Google Scholar]
  3. Black J. D., Dolly J. O. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol. 1986 Aug;103(2):535–544. doi: 10.1083/jcb.103.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boroff D. A., del Castillo J., Evoy W. H., Steinhardt R. A. Observations on the action of type A botulinum toxin on frog neuromuscular junctions. J Physiol. 1974 Jul;240(2):227–253. doi: 10.1113/jphysiol.1974.sp010608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cull-Candy S. G., Lundh H., Thesleff S. Effects of botulinum toxin on neuromuscular transmission in the rat. J Physiol. 1976 Aug;260(1):177–203. doi: 10.1113/jphysiol.1976.sp011510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dolly J. O., Black J., Williams R. S., Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature. 1984 Feb 2;307(5950):457–460. doi: 10.1038/307457a0. [DOI] [PubMed] [Google Scholar]
  7. Dreyer F., Schmitt A. Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature. Pflugers Arch. 1983 Nov;399(3):228–234. doi: 10.1007/BF00656720. [DOI] [PubMed] [Google Scholar]
  8. Fertuck H. C., Salpeter M. M. Quantitation of junctional and extrajunctional acetylcholine receptors by electron microscope autoradiography after 125I-alpha-bungarotoxin binding at mouse neuromuscular junctions. J Cell Biol. 1976 Apr;69(1):144–158. doi: 10.1083/jcb.69.1.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fertuck H. C., Salpeter M. M. Sensitivity in electron microscope autoradiography for 125I. J Histochem Cytochem. 1974 Feb;22(2):80–87. doi: 10.1177/22.2.80. [DOI] [PubMed] [Google Scholar]
  10. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grafstein B., Forman D. S. Intracellular transport in neurons. Physiol Rev. 1980 Oct;60(4):1167–1283. doi: 10.1152/physrev.1980.60.4.1167. [DOI] [PubMed] [Google Scholar]
  12. Gundersen C. B., Katz B., Miledi R. The antagonism between botulinum toxin and calcium in motor nerve terminals. Proc R Soc Lond B Biol Sci. 1982 Oct 22;216(1204):369–376. doi: 10.1098/rspb.1982.0080. [DOI] [PubMed] [Google Scholar]
  13. Habermann E. 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedebergs Arch Pharmacol. 1974;281(1):47–56. doi: 10.1007/BF00500611. [DOI] [PubMed] [Google Scholar]
  14. Hagenah R., Benecke R., Wiegand H. Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;299(3):267–272. doi: 10.1007/BF00500319. [DOI] [PubMed] [Google Scholar]
  15. Hanig J. P., Lamanna C. Toxicity of botulinum toxin: a stoichiometric model for the locus of its extraordinary potency and persistence at the neuromuscular junction. J Theor Biol. 1979 Mar 7;77(1):107–113. doi: 10.1016/0022-5193(79)90141-3. [DOI] [PubMed] [Google Scholar]
  16. Harris A. J., Miledi R. The effect of type D botulinum toxin on frog neuromuscular junctions. J Physiol. 1971 Sep;217(2):497–515. doi: 10.1113/jphysiol.1971.sp009582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hendry I. A. The effect of the retrograde axonal transport of nerve growth factor on the morphology of adrenergic neurones. Brain Res. 1977 Oct 7;134(2):213–223. doi: 10.1016/0006-8993(77)91068-x. [DOI] [PubMed] [Google Scholar]
  18. Heuser J. E., Reese T. S., Landis D. M. Functional changes in frog neuromuscular junctions studied with freeze-fracture. J Neurocytol. 1974 Mar;3(1):109–131. doi: 10.1007/BF01111936. [DOI] [PubMed] [Google Scholar]
  19. Hirokawa N., Heuser J. E. Structural evidence that botulinum toxin blocks neuromuscular transmission by impairing the calcium influx that normally accompanies nerve depolarization. J Cell Biol. 1981 Jan;88(1):160–171. doi: 10.1083/jcb.88.1.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hirokawa N., Kitamura M. Localization of radioactive I25I-labelled botulinus toxin at the neuromuscular junction of mouse diaphragm. Naunyn Schmiedebergs Arch Pharmacol. 1975;287(1):107–110. doi: 10.1007/BF00632642. [DOI] [PubMed] [Google Scholar]
  21. Holtzman E. The origin and fate of secretory packages, especially synaptic vesicles. Neuroscience. 1977;2(3):327–355. doi: 10.1016/0306-4522(77)90001-x. [DOI] [PubMed] [Google Scholar]
  22. Kelly A. M., Zacks S. I. The fine structure of motor endplate morphogenesis. J Cell Biol. 1969 Jul;42(1):154–169. doi: 10.1083/jcb.42.1.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Matthews-Bellinger J., Salpeter M. M. Distribution of acetylcholine receptors at frog neuromuscular junctions with a discussion of some physiological implications. J Physiol. 1978 Jun;279:197–213. doi: 10.1113/jphysiol.1978.sp012340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Porter C. W., Barnard E. A. The density of cholinergic receptors at the endplate postsynaptic membrane: ultrastructural studies in two mammalian species. J Membr Biol. 1975;20(1-2):31–49. doi: 10.1007/BF01870626. [DOI] [PubMed] [Google Scholar]
  25. Price D. L., Griffin J., Young A., Peck K., Stocks A. Tetanus toxin: direct evidence for retrograde intraaxonal transport. Science. 1975 May 30;188(4191):945–947. doi: 10.1126/science.49080. [DOI] [PubMed] [Google Scholar]
  26. Pumplin D. W., Reese T. S. Action of brown widow spider venom and botulinum toxin on the frog neuromuscular junction examined with the freeze-fracture technique. J Physiol. 1977 Dec;273(2):443–457. doi: 10.1113/jphysiol.1977.sp012103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Salpeter M. M., Bachmann L., Salpeter E. E. Resolution in electron microscope radioautography. J Cell Biol. 1969 Apr;41(1):1–32. doi: 10.1083/jcb.41.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Salpeter M. M., Szabo M. Sensitivity in electron microscope autoradiography. I. The effect of radiation dose. J Histochem Cytochem. 1972 Jun;20(6):425–434. doi: 10.1177/20.6.425. [DOI] [PubMed] [Google Scholar]
  29. Sellin L. C., Thesleff S., Dasgupta B. R. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction. Acta Physiol Scand. 1983;119(2):127–133. doi: 10.1111/j.1748-1716.1983.tb07317.x. [DOI] [PubMed] [Google Scholar]
  30. Simpson L. L. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther. 1980 Jan;212(1):16–21. [PubMed] [Google Scholar]
  31. Simpson L. L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev. 1981 Sep;33(3):155–188. [PubMed] [Google Scholar]
  32. Sugiyama H. Clostridium botulinum neurotoxin. Microbiol Rev. 1980 Sep;44(3):419–448. doi: 10.1128/mr.44.3.419-448.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tse C. K., Dolly J. O., Hambleton P., Wray D., Melling J. Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur J Biochem. 1982 Mar 1;122(3):493–500. [PubMed] [Google Scholar]
  34. Tsuji S. On the chemical basis of thiocholine methods for demonstration of acetylcholinesterase activities. Histochemistry. 1974;42(1):99–110. doi: 10.1007/BF00498482. [DOI] [PubMed] [Google Scholar]
  35. Valtorta F., Madeddu L., Meldolesi J., Ceccarelli B. Specific localization of the alpha-latrotoxin receptor in the nerve terminal plasma membrane. J Cell Biol. 1984 Jul;99(1 Pt 1):124–132. doi: 10.1083/jcb.99.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Williams R. S., Tse C. K., Dolly J. O., Hambleton P., Melling J. Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem. 1983 Mar 15;131(2):437–445. doi: 10.1111/j.1432-1033.1983.tb07282.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES